Join Growin Stock Community!

全科3209.TW Overview

TW StockElec. Products Dist.
(No presentation for 3209)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

全科（3209）Overall Performance

全科（3209）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

全科（3209） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

全科（3209）Key Information

全科（3209）Profile

Alltek Technology Corporation operates as a communication components distributor and solution provider in Taiwan and internationally. The company provides broadband access devices used in C/O products, computer devices, servers, modems, and network communication products; wireless communication devices for use in PC, NB, servers, auto control products, mobile devices, mobile phones, and portable consumer products; and optical devices for O/E, Internet, and network communication applications. It also offers voice processing devices for use in PC, NB, servers, O/E products, gateways, network communication products, and modems; and protection devices for use in O/E products, gateways, network communication products, and modems. In addition, the company provides self-developed products for ASIC, DAA, SLIC modules, pair gains, switch routers, power management devices, memory products, display drivers, and AIS applications, as well as time-to-market and value-added services. Alltek Technology Corporation was founded in 1991 and is based in Taipei, Taiwan.

全科（3209）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.21
PE Ratio (TTM)
15.91
Forward PE
11.28
PS Ratio (TTM)
0.18
PB Ratio
1.64
Price-to-FCF
4.16
METRIC
VALUE
vs. INDUSTRY
Gross Margin
5.09%
Net Margin
1.14%
Revenue Growth (YoY)
-11.76%
Profit Growth (YoY)
-6.78%
3-Year Revenue Growth
-8.65%
3-Year Profit Growth
-0.09%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
2.21
PE Ratio (TTM)
15.91
Forward PE
11.28
PS Ratio (TTM)
0.18
PB Ratio
1.64
Price-to-FCF
4.16
Gross Margin
5.09%
Net Margin
1.14%
Revenue Growth (YoY)
-11.76%
Profit Growth (YoY)
-6.78%
3-Year Revenue Growth
-8.65%
3-Year Profit Growth
-0.09%
default symbol

3209

全科

35.20D

-1.56%

(-0.02)

  • When is 3209's latest earnings report released?

    The most recent financial report for 全科 (3209) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 3209's short-term business performance and financial health. For the latest updates on 3209's earnings releases, visit this page regularly.

  • Where does 3209 fall in the P/E River chart?

    According to historical valuation range analysis, 全科 (3209)'s current price-to-earnings (P/E) ratio is 9.78, placing it in the Overvalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning optimistic. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 3209?

    According to the latest financial report, 全科 (3209) reported an Operating Profit of 218.69M with an Operating Margin of 1.87% this period, representing a decline of 48.96% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 3209's revenue growth?

    In the latest financial report, 全科 (3209) announced revenue of 11.67B, with a Year-Over-Year growth rate of -13.82%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 3209 have?

    At the end of the period, 全科 (3209) held Total Cash and Cash Equivalents of 3.47B, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 3209 go with three margins increasing?

    In the latest report, 全科 (3209) achieved the “three margins increasing” benchmark, with a gross margin of 5.72%%, operating margin of 1.87%%, and net margin of 2.57%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 3209's profit trajectory and future growth potential.

  • Is 3209's EPS continuing to grow?

    According to the past four quarterly reports, 全科 (3209)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.27. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 3209?

    全科 (3209)'s Free Cash Flow (FCF) for the period is -218.67M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 33.03% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.